First exosome-based liquid biopsy test receives FDA’s breakthrough device designation

June 19, 2019 Leave a comment

Bio-Techne today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to its ExoDx Prostate IntelliScore (EPI) test, making it the first exosome-based liquid biopsy test to receive a Breakthrough Device Designation. This designation not ...

Exosome RNA Exosome RNA Research & Industry News

Tag Archives: U.S. Food and Drug Administration

First exosome-based liquid biopsy test receives FDA’s breakthrough device designation

Researchers identify biomarker panel from extracellular vesicles that could help predict gestational diabetes in early pregnancy

Evox Therapeutics Presents Progress Across its DeliverEX™ Exosome Therapeutics Platform

A more efficient method to load isolated biovesicles with cargo that can functionally modified recipient cells

An optimized method for the isolation of urinary extracellular vesicles for detection of biomarkers for radiation exposure

The 1st Inaugural International Conference of Exosomal Research

Exosomes: The “Off-the-Shelf” Cellular Nanocomponent as a Potential Pathogenic Agent, a Disease Biomarker, and Neurotherapeutics